C. Suppli Ulrik (Virum, Denmark), S. Loukides (Athens, Greece)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
A. Markus (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), J. Kors (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium), E. Burn (Oxford, United Kingdom), D. Prieto-Alhambra (Oxford, United Kingdom), K. Verhamme (Rotterdam, Netherlands)
|   |
Triple combination therapy in severe asthma: overview from the Italian Registry Severe Asthma (IRSA)
C. Micheletto (Verona, Italy), M. Bilò (Ancona, Italy), L. Antonicelli (Ancona, Italy), F. De Michele (Napoli, Italy), A. Musarra (Reggio Calabria, Italy), A. Vaghi (Garbagnate Milanese (MI), Italy)
| |
Annual systemic and inhaled corticosteroid exposures in US patients =4 years with asthma
M. Lanz (Coral Gables, United States of America), I. Gilbert (Wilmington, United States of America), M. Pollack (Wilmington, United States of America), H. Gandhi (Wilmington, United States of America), J. Tkacz (Cambridge, United States of America), N. Lugogo (Ann Arbor, United States of America)
| |
Mindfulness based cognitive therapy in poorly controlled asthma: Will patients attend and do they benefit?
S. Smith (Glasgow, United Kingdom), M. Mcguigan (Glasgow, United Kingdom), B. O'Dowd (Glasgow, United Kingdom), N. Lee (Glasgow, United Kingdom), F. Yang (Glasgow, United Kingdom), T. Grandison (Glasgow, United Kingdom), V. Noguera (Glasgow, United Kingdom), K. Bissett (Glasgow, United Kingdom), M. Shepherd (Glasgow, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom)
| |
Bronchial Thermosplaty and severe asthma with frequent severe exacerbations : a controlled study.
J. Leroux (Strasbourg, France), N. Khayath (Strasbourg, France), C. Matau (Strasbourg, France), D. Ochea (Strasbourg, France), F. Lefebvre (Strasbourg, France), A. Molard (Strasbourg, France), F. De Blay (Strasbourg, France)
| |
Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme
D. Attar (London, United Kingdom), T. Capstick (Leeds, United Kingdom), D. Leese (Sheffield, United Kingdom), S. Arnetorp (Gothenburg, Sweden), E. Rapsomaniki (Cambridge, United Kingdom), K. Da Costa (Cambridge, United Kingdom), Y. Xu (Cambridge, United Kingdom), J. Quint (London, United Kingdom)
| |
Efficacy of different dosing regimens of azithromycin in a real-world severe asthma cohort
A. Kumar (Liverpool, United Kingdom), S. Zaidi (Liverpool, United Kingdom), N. Fay (Liverpool, United Kingdom), T. Fitzmaurice (Liverpool, United Kingdom), A. Watkin (Liverpool, United Kingdom), H. Joplin (Liverpool, United Kingdom), H. Burhan (Liverpool, United Kingdom)
| |
A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol.
C. Mortimer (Crawley, United Kingdom)
| |
Oral corticosteroids-related comorbidities in severe asthma
A. Vaghi (Garbagnate Milanese (MI), Italy), L. Antonicelli (Ancona, Italy), M. Bilò (Ancona, Italy), F. De Michele (Napoli, Italy), C. Micheletto (Verona, Italy), A. Musarra (Reggio Calabria, Italy)
| |
Evaluation of Asthma control and oral corticosteroids in Severe Asthma
C. Micheletto (Verona, Italy), M. Bilò (Ancona, Italy), L. Antonicelli (Ancona, Italy), F. De Michele (Napoli, Italy), A. Musarra (Reggio Calabria, Italy), A. Vagni (Garbagnate Milanese (MI), Italy)
| |
Implementation of a nursing led intervention bundle in the Emergency Department : Outcomes
W. Lim (Singapore, Singapore), W. Yeung (Singapore, Singapore), N. Ling (Singapore, Singapore), L. Neo (Singapore, Singapore), L. Prabhakaran (Singapore, Singapore), N. Bte Said (Singapore, Singapore), J. Bte Noor Mohamed (Singapore, Singapore), M. Liew (Singapore, Singapore), P. Pang (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), T. Lim (Singapore, Singapore), H. Lim (Singapore, Singapore)
| |
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
H. Hao (Shanghai, China), W. Bao (Shanghai, China), Y. Xue (Shanghai, China), Y. Zhou (Shanghai, China), Z. Huang (Shanghai, China), D. Yin (Shanghai, China), Y. Zhang (Shanghai, China), P. Zhang (Shanghai, China), C. Lv (Shanghai, China), L. Han (Shanghai, China), X. Zhou (Shanghai, China), J. Yin (Shanghai, China), M. Zhang (Shanghai, China)
| |
Use of health care and management of asthma patients in the emergency room during the COVID 19 pandemic: lessons for the next wave.
S. Foulquier (Toulouse, France), E. Noel Savina (Toulouse, France), L. Guilleminault (Toulouse, France), A. Didier (Toulouse, France), F. Balen (Toulouse, France)
| |
The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review
C. Mortimer (Crawley, United Kingdom), D. Nikoletou (London, United Kingdom), A. Ooms (London, United Kingdom), J. Williams (Crawley, United Kingdom)
| |
Inhaled antibiotic therapy in patients with severe asthma
E. AVALOS PEREZ-URRIA (Madrid , Spain), R. Girón Moreno (Madrid , Spain), C. Cisneros Serrano (Madrid , Spain), E. Martínez Besteiro (Madrid , Spain), M. Erro Iribarren (Madrid , Spain), A. Martínez Vergara (Madrid , Spain), E. García Castillo (Madrid , Spain), A. Martínez Meca (Madrid , Spain), J. Ancochea (Madrid , Spain)
| |
Shared decision making in severe asthma therapy: qualitative study of physician-patient communication
E. Lu (Collegeville, United States of America), K. Solovyeva (Philadelphia, United States of America), Z. Hebert (Philadelphia, United States of America), L. Kietzer (Philadelphia, United States of America), S. Griffiths (Brentford, London, United Kingdom), Z. Antoun (Brentford, London, United Kingdom), T. Keeley (Brentford, London, United Kingdom), R. Alfonso-Cristancho (Collegeville, United States of America)
| |
Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria
C. Hopkins (London, United Kingdom), J. Han (Norfolk, VA, United States of America), V. Lund (London, United Kingdom), C. Bachert (Ghent, Belgium), Z. Diamant (Leuven, Belgium), W. Fokkens (Amsterdam, Netherlands), A. Sousa (London, United Kingdom), S. Smith (Research Triangle Park, NC, United States of America), S. Yang (Collegeville, PA, United States of America), B. Mayer (London, United Kingdom), S. Yancey (Research Triangle Park, NC, United States of America), R. Chan (London, United Kingdom), S. Lee (Pittsburgh, PA, United States of America)
| |
Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy
J. Kroes (Leeuwarden, Netherlands), S. Zielhuis (Groningen, Netherlands), K. De Jong (Leeuwarden, Netherlands), S. Zielhuis (Leeuwarden, Netherlands), E. Van Roon (Groningen, Netherlands), E. Bel (Amsterdam, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
| |
Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study
M. Lommatzsch (Rostock, Germany), S. Korn (Mainz, Germany), T. Plate (Wedel, Germany), T. Grund (Wedel, Germany), H. Watz (Grosshansdorf, Germany)
| |
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
C. Pilette (Bruxelles, Belgium), G. Canonica (Milan, Italy), R. Chaudhuri (Glasgow, United Kingdom), F. Lee (Atlanta, GA, United States of America), J. Lee (Toronto, ON, Canada), C. Almonacid Sanchez (Madrid, Spain), R. Alfonso-Cristancho (Collegeville, PA, United States of America), R. Jakes (London , United Kingdom), A. Maxwell (Stevenage, United Kingdom), R. Price (Stevenage, United Kingdom), P. Howarth (Brentford, United Kingdom)
| |